Publications
Publications
Show Results For
- All HBS Web
(2,842)
- Faculty Publications (1,201)
- August 2001 (Revised March 2016)
- Case
Doral Costa
By: William J. Poorvu, John H. Vogel Jr., Arthur I. Segel and Amy Silverstein
Doral Costa is a proposed 277,803 square foot Class A office park development in Miami, FL. Trammell Crow Co. would like to develop this office park in joint venture with a partner. Samantha Spar, the acquisitions partner at Titan Associates, a large real estate... View Details
- August 2001 (Revised February 2020)
- Case
Consumer-Driven Health Care: Medtronic's Health Insurance Options
By: Regina E. Herzlinger, John Hurwitch and Seth Bokser
Describes the variety of health insurance plans that this medical device company offers, including a high-deductible, consumer-driven health plan with a health reimbursement account that also enables health care providers to quote their own prices. Asks students to... View Details
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- July 2001
- Technical Note
Technical Note on LBO Valuation (A): LBO Structure and the Target IRR Method of Valuation
Explains the equity cash flow method of valuation as it applies to leveraged buyouts. Also explains: 1) earnings and cash flow forecasts, 2) debt structure and the cash sweep, 3) the cashing out horizon and terminal valuation, and 4) the target IRR method of valuation. View Details
- July 2001
- Technical Note
Technical Note on LBO Valuation (B): The Equity Cash Flow Method of Valuation using CAPM
Explains the equity cash flow method of valuation as it applies to leveraged buyouts. Also explains how to implement the changing cost of equity method using the CAPM. View Details
- July 2001 (Revised August 2005)
- Case
Medicines Company, The
It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The... View Details
- June 2001 (Revised July 2001)
- Case
Amazon.com in the Year 2000
By: Krishna G. Palepu and Jeremy Cott
An analyst's critique of Amazon's prospectus from the perspective of its bond holders. View Details
- Article
The Market for Catastrophe Risk: A Clinical Examination
By: K. A. Froot
- April 2001 (Revised November 2001)
- Case
AvantGo
By: Alan D. MacCormack and Kerry Herman
Richard Owen, CEO of AvantGo, is preparing for a meeting in which he will set the human resource policy for the firm going forward. It has been three months since the company's IPO, and given the tremendous cramp in hiring over the six months prior to the IPO, he knows... View Details
- April 2001 (Revised July 2001)
- Case
Zaplet, Inc.
By: Dorothy A. Leonard and Brian DeLacey
Start-up Zaplet, Inc., has radical software, prestigious venture capital funding, and a multitude of business opportunities. New CEO Alan Baratz must select a strategy and redesign the organization to deliver. This case describes the roles and philosophies of the... View Details
- April 2001 (Revised July 2001)
- Case
Verge Software (A)
By: Dorothy A. Leonard and Elizabeth Kind
Scott Rozic, CEO of start-up Verge Software, has just told his board that he is taking the company in a totally new direction, moving from enterprise knowledge management software to Internet direct marketing. This case covers the start-up of the business, and Rozic's... View Details
Keywords: Venture Capital; Investment; Corporate Entrepreneurship; Business or Company Management; Business Strategy; Technological Innovation; Applications and Software; Management Teams; Governing and Advisory Boards; Business Startups; Decision Choices and Conditions; Product Development; Information Technology Industry; United States
- March 2001 (Revised October 2001)
- Case
Honest Tea
By: Paul A. Gompers
This case examines the decisions of Seth Goldman and Barry Nalebuff, founders of Honest Tea. Honest Tea is a start-up in the ready-to-drink tea market. Goldman and Nalebuff must craft an expansion and financing strategy. View Details
- February 2001 (Revised April 2001)
- Case
CDC Capital Partners
By: G. Felda Hardymon, Josh Lerner and Ann Leamon
In 2001, CDC Capital Partners is facing the greatest challenge in its 53-year history. Founded as part of the U.K. government's post-war colonial reconstruction, it had operated as a developmental finance institution, largely issuing debt to the world's poorest... View Details
- February 2001 (Revised June 2001)
- Case
ClubTools, Inc.
By: Paul W. Marshall and Kristin Perry
Discusses the development of an Internet start-up by a recent HBS graduate. Details the company's business plan, incubation, technology development, marketing strategy, and search for funding. View Details
- February 2001
- Case
Bang Networks, Inc.
By: Paul A. Gompers and Sergio Rattner
Bob Rosin, president and CEO of Bang Networks, must decide how much debt financing to take on. The company is a raw start-up and is considering taking on $10 million in debt. The firm has six offers and needs to identify the best one. View Details
- February 2001
- Case
ALWAYSi
By: Paul A. Gompers and Sergio Rattner
Anthony Soohoo, COO at ALWAYSi, an independent film distributor, is preparing projections for the company. Soohoo must decide which revenue streams the company should pursue. The firm is faced with a variety of attractive opportunities. View Details
- February 2001
- Article
The Portfolio Flows of International Investors
By: K. A. Froot, P. O'Connell and M. Seasholes
- February 2001
- Article
Transaction Decoupling: How Price Bundling Affects the Decision to Consume
By: Dilip Soman and J. T. Gourville
- January 2001 (Revised March 2002)
- Case
Ford Motor Company's Value Enhancement Plan
By: Andre F. Perold
In April 2000, Ford Motor Co. announced a shareholder Value Enhancement Plan (VEP) to significantly recapitalize the firm's ownership structure. Ford had accumulated $23 billion in cash reserves and under the VEP would return as much as $10 billion of this cash to... View Details